![Joshua Riggs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joshua Riggs
Chief Executive Officer at
INSIGHT MOLECULAR DIAGNOSTICS INC.
Net worth: 178 397 $ as of 30/07/2026
Profile
Joshua Riggs was the founder of Intelliger Consulting LLC, founded in 2015, and served as Principal from 2015 to 2020.
Mr. Riggs is currently President, Chief Executive Officer & Director at Insight Molecular Diagnostics, Inc., starting in 2023.
Former positions include Principal at Bethesda Group LLC from 2016 to 2020.
Education includes an MBA from the University of Mississippi and an undergraduate degree from Adelphi University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/04/2026 | 38,365 ( 0.13% ) | 178 397 $ | 30/07/2026 |
Joshua Riggs active positions
| Companies | Position | Start |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Chief Executive Officer | 30/11/2022 |
Former positions of Joshua Riggs
| Companies | Position | End |
|---|---|---|
Bethesda Group
 Bethesda Group Investment ManagersFinance Bethesda Group invests in companies located in the United States. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 30/06/2020 |
Training of Joshua Riggs
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Adelphi University
 Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mississippi
 University of Mississippi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Bethesda Group
Bethesda Group Investment ManagersFinance Bethesda Group invests in companies located in the United States. The firm focuses on the biotechnology sector. It provides financing for early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Joshua Riggs
